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been deployed since September 2001 than in the previous 40 years. 
A greater number of these deployed service members are surviving, 
which has increased the incidence of combat-related PTSD among 
those veterans (Callahan, 2010). For example, Iraq and Afghanistan 
War veterans who showed PTSD symptoms were four times more 
likely to endorse suicidal ideation than their non-PTSD counterparts 
(Jakupcak et al., 2009). These evidences suggest that fearful memo-
ries and PTSD symptoms may contribute to suicidal ideation and 
attempts, and individual vulnerability to traumatic events is one of 
the risk factors for suicide (Ursano et al., 2010). However, precise 
molecular mechanisms underlying how fear and stress trigger sui-
cidal behavior in humans are not clearly understood.
Multiple brain regions have been implicated in emotional 
learning and memory. Among those, the PFC is one of the 
key brain regions that integrates stress signals and subsequent 
 decision-making process in humans. Protein phosphorylation in 
the brain plays a critical role in triggering synaptic changes that 
are associated with emotional learning and memory (Fischer 
et al., 2003). Intracellular phosphorylation is orchestrated by 
a complex network of many different kinases including pro-
tein kinase C (PKC), calcium/calmodulin-dependent protein 
kinase (CAMK), mitogen-activated protein kinase (MAPK), and 
cyclin- dependent kinase (CDK). PKC is a critical phosphorylat-
ing enzyme in the phosphoinositide signaling pathway. Previous 
IntroductIon
Physical and mental threat can induce fear responses, and fear can 
be associated with objects and places through a process of Pavlovian 
fear conditioning (Ledoux, 2000). The process of fear learning and, 
importantly, its “overriding” or fear extinction is dependent on the 
amygdala and the prefrontal cortex (PFC). Stress is a multi-dimen-
sional challenge to physical and mental homeostasis that can be trig-
gered by fear (Kim and Diamond, 2002; McEwen, 2007), and both 
acute and chronic stress can alter the properties of fear (Conrad et al., 
1999; Rodrigues et al., 2009). A growing body of evidence suggests 
that fear and traumatic stress may contribute to the pathophysiology 
of suicide. For instance, suicidal ideation was significantly associ-
ated with traumatic life events and the effects of traumatic stress 
on suicidal behavior may be mediated by feelings of hopelessness 
(Tarrier and Picken, 2010; Guerra and Calhoun, 2011). A study using 
a large scale of civilian population (N = 34,653) found that over 
70% of the individuals who reported a lifetime history of a suicide 
attempt had anxiety disorders (Nepon et al., 2010). Interestingly, 
individuals with comorbidity of personality disorders such as neu-
roticism and posttraumatic stress disorder (PTSD) showed a much 
stronger association with suicide attempts than those who had PTSD 
alone. In a military population, more U.S. service members have 
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studies have suggested that these kinases such as PKC, CAMK, 
MAPK, and CDK also regulate fear conditioning and extinction 
in animals (Schafe et al., 2000; Li et al., 2002; Frankland et al., 
2004; Lepicard et al., 2006; Sananbenesi et al., 2007; Bergstrom 
et al., 2011). For example, chronic administration of a PKC 
inhibitor reduced the acquisition of conditioned fear memory 
suggesting the involvement of PKC in the synaptic plasticity and 
memory (Li et al., 2002). On the contrary, another study reported 
that inhibition of PKC signaling protected dendritic spines in 
the PFC and rescued working memory impairment caused by 
chronic stress (Hains et al., 2009). The authors suggested that 
PKC inhibitors may act as neuroprotective agents in fear and 
stress-related disorders. CAMK is also involved in hippocampal-
dependent contextual learning in rodents (Kouzu et al., 2000). 
Among the individuals with psychiatric disorders, the expression 
levels of CaMKII beta (CAMK2B) were increased in the PFC 
of individuals with schizophrenia (27%) and individuals with 
depression (36%) as compared to the unaffected controls (Novak 
et al., 2006). Because CAMK2B regulates important functions in 
the brain such as neurotransmitter signaling, neural outgrowth, 
and pruning, its increased expression in the PFC of the individu-
als with psychiatric disorders may have important implications. 
Moreover, inhibition of the MAPK pathway in the hippocampus 
abolished the increased contextual fear conditioning induced by 
glucocorticoids in mice (Revest et al., 2005). This suggests that 
the MAPK pathway interacts with the glucocorticoid system in 
fear learning and memory. Another kinase, cyclin-dependent 
kinase 5 (CDK5), has been implicated in learning and memory 
(Fischer et al., 2003). CDK5 plays a role during neurodevelop-
mental processes, such as interactions with distinct cytoplasmic 
and synaptic target molecules, and synaptic plasticity underlying 
memory consolidation in the adult brain. It has been shown that 
extinction of fear memory requires down-regulation of CDK5 
activity in the mouse hippocampus (Sananbenesi et al., 2007). 
Taken together, these studies indicate that multiple kinase sys-
tems contribute to regulation of emotional learning and memory, 
and subsequent behavioral responses in animals and in humans.
Recent advances in genomic technologies utilizing postmor-
tem brain tissue have made significant progress toward more 
analytical and informative research in psychiatry (Harrison, 2011; 
Mccullumsmith and Meador-Woodruff, 2011). However, identify-
ing potential susceptibility genes associated with suicide has been 
challenging (Mann et al., 2009; Tsai et al., 2011). We have shown 
that gene expression changes in postmortem brain tissue are subtle 
possibly due to a relatively small sample size, known and unknown 
confounding factors, and diagnostic heterogeneity among psychiat-
ric patients (Choi et al., 2008). Given that multiple kinase genes are 
implicated in the mechanisms of fear and stress, and fear and stress 
are the major risk factors for suicidal behavior, we hypothesized 
that the kinases genes may be involved in the pathophysiology of 
suicidal behavior. Thus, we investigated the expression profiles of 
four major kinase genes including protein kinase C (PKC), cal-
cium/calmodulin-dependent protein kinase (CAMK), mitogen-
activated protein kinase (MAPK), and CDK in the PFC of mood 
disorder patients died with and without suicide. In order to study 
the developmental expression pattern of the same genes, we meas-
ured mRNA levels in the PFC of normal individuals ranging in age 
from birth to 49 years. Using gene expression microarrays from 
the postmortem brain tissue, we aimed to identify potential kinase 
genes that are associated with both chronological age and suicide.
MaterIals and Methods
PostMorteM braIn tIssue
Gene expression microarray datasets from the individuals with 
mood disorders with suicide (N = 45) and without suicide (N = 38) 
were obtained from the Stanley Online Genomics database (see 
text footnote 1). The details of the brain sample collection have 
been described previously (Torrey et al., 2000). Developmental 
brain tissue from the PFC of subjects (N = 46) ranging in age 
from 1 month to 49 years was obtained from the National Institute 
of Child Health and Human Development Brain and Tissue 
Bank for Developmental Disorders (UMBB; NICHHD contract# 
NO1-HD8-3283). The collection protocol was reviewed and 
approved by the Institutional Review Board of the University of 
Maryland, Baltimore. For the developmental brains, all subjects 
were free of neurological and psychiatric symptoms at the time of 
death as described previously (Choi et al., 2009). Developmental 
brain microarray raw data are available from the gene expression 
omnibus (GEO) with an Accession number GSE11512.
MIcroarray exPerIMent
Total RNA was extracted from gray matter of the PFC (BA 46) and 
using the Trizol method (Invitrogen, Carlsbad, CA, USA). Samples 
were included only if the RNA was of good quality (RNA integrity 
number, RIN > 7) as determined by the Bioanalyzer 2100 elec-
trophoresis system (Agilent Technologies, Foster City, CA, USA). 
Purified RNA was carried through the Affymetrix preparation pro-
tocol2, and each sample was hybridized to the different Affymetrix 
platform such as HGU95av2, HGU 133a, HGU 133b, or HGU133 
plus 2.0 GeneChip to assess genome-wide expression profiles. RNA 
processing and microarray data generation was performed by the 
individual investigators at their own facilities as described previ-
ously (Choi et al., 2008).
QualIty control of MIcroarrays
Raw microarray data were processed and analyzed using the R sta-
tistical language3 and the Bioconductor packages (Gentleman et al., 
2004). A robust multi-array average (RMA) algorithm was used for 
normalization of expression values (log base 2) for each transcript 
(Irizarry et al., 2003). Microarray data quality was assessed using a 
pair-wise sample correlation coefficient with hierarchical cluster-
ing. Transcripts were filtered out if 20% or more of the subjects had 
expression values of less than a 1.1-fold change in either direction 
from the transcript’s median value and if the percent of subjects 
with an absent gene call exceeded 33% using the Affymetrix calls.
MIcroarray analysIs of the develoPMental braIns
First, we analyzed individual demographic factors including brain 
pH, postmortem interval (PMI), RIN, race, and sex to identify 
potential confounds affecting the expression of a significant number 
of genes (p < 0.001). Following the demographic variable analyses, 
2www.Affymetrix.com
3http://www.r-project.org
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non-suicide group (p < 0.05). Thus, we adjusted for age, mood 
disorder (bipolar disorder and major depression) and duration of 
illness in the following suicide analysis using a multiple regression 
model. Among the 45 suicide cases, a majority of the subjects died 
of drug overdose (36%), hanging (29%), jumped (11%), and gun 
shot wound (9%).
Figure 1 shows the expression profiles of CAMK2B in the PFC 
of normal individuals ranging in age from birth to 49 years (A) 
and suicide victims as compared to the non-suicide subjects (B). 
The expression levels of CAMK2B in the PFC were gradually 
decreased during the postnatal development (r2 = 0.69, qv = 1.1E-
11). Each subject was color-coded based on the arbitrary age 
group such as neonate (red), infant (green), toddler (blue), school 
age (magenta), teenage (pink), young adult (yellow), and adult 
(gray). A combined analysis of the microarray studies shows that 
CAMK2B expression levels are significantly increased in the PFC 
of suicide victims as compared to the non-suicide subjects (FC: 
1.13, qv = 0.009). There are multiple microarray probes (N = 2–5) 
for CAMK2B in each study and those probes show consistent 
changes in expression levels. Although most of the individual 
studies did not show significant changes, the combined analysis 
(shown on the bottom) showed consensus increases in expres-
sion in the suicide group as compared to the non-suicide group.
The expression levels of CDK5 in the PFC during postnatal 
development show inverted U-shape (Figure 2A). Specifically, the 
expression levels of CDK5 in the PFC were increased until 10 years 
of age (r2 = 0.18, qv = 0.035) and then gradually decreased until 
49 years (r2 = 0.23, qv = 0.029). A combined analysis of the micro-
array studies shows that CDK5 expression levels are increased in 
the PFC of suicide victims as compared to the non-suicide subjects 
(FC: 1.19, qv = 0.04) as shown in Figure 2B. Individual studies did 
not show significant changes but a combined analysis (shown on 
the bottom) showed a significant up-regulation of CDK5 in the 
PFC of suicide victims.
Figure 3A shows that the expression levels of mitogen-activated 
protein kinase 9 (MAPK9) in the PFC are gradually increased in the 
PFC of normal individuals ranging in age from birth to 49 years 
(r2 = 0.64, qv = 1.2E-05). The expression levels consistently increased 
gene expression across chronological age was analyzed in a series 
of multiple regression models, one model for each gene, including 
age (log base 2) and brain pH as independent variables and gene 
expression (log base 2) as a dependent variable (Choi et al., 2009). 
To correct for multiple testing of the genes, the calculated p-values 
corresponding to the age covariate for each gene were adjusted to 
give an overall false discovery rate (FDR) of 5% using the q-value 
(qv) package4. The criteria of significance were set at qv < 0.05.
MIcroarray analysIs of Mood dIsorder wIth and wIthout 
suIcIde
Mood disorder subjects were divided into two groups: those with 
suicide (N = 45) and those without suicide (N = 38). Each pre- and 
post-mortem variable was compared between the suicide and the 
non-suicide group. We identified the variables including age, mood 
disorder, and duration of illness that were different between the 
two groups (p < 0.05). Thus, we adjusted for these variables in the 
following suicide analysis using multiple regression models. For an 
individual study analysis, we performed a linear regression analysis 
to calculate an adjusted fold change, SE, and p-value for each gene 
in each study. We then performed a cross-study comparison based 
on scaled representations of individual study-level analysis across 
nine microarray studies. Consensus fold change was calculated for 
each gene based on a weighted combination of the individual fold 
changes and the SEs for the microarray probe sets that map to 
each gene across the studies as described previously (Choi et al., 
2008). Weights were determined in a probe set specific manner to 
account for the different levels of precision associated with each 
probe set that map to a given gene across the studies. The weights 
were equal to 1/SEi, where SEi is the SE of the ith probe set for the 
gene across all the studies. To adjust for multiple testing of the genes, 
the calculated p-values corresponding to the suicide group were 
adjusted to give an overall FDR of 5% using the qv package. The 
criteria of significance were set at qv < 0.05 and fold change >1.1.
bIoInforMatIcs MaPPIngs
The NCBI’s Database for Annotation, Visualization, and Integrated 
Discovery  was used as the standard source for gene annotation 
information [22]. The primary fields extracted from the DAVID 
include: Entrez ID, gene symbol, gene name, and gene summary. 
For the microarrays, queries were based on the Affymetrix probe 
set ID (AFFYID).
results
A summary of the subject characteristics included in the microarray 
studies is shown in Table 1. There were no significant differences 
in sex, race, brain pH, and PMI between the suicide and the non-
suicide group; this is important since these pre- and post-mortem 
variables appear to influence gene expression in the postmortem 
brain tissue. The number of bipolar disorder subjects was slightly 
higher in the non-suicide group (66 vs. 51%) while the number 
of major depression subjects was higher in the suicide group (49 
vs. 34%). Other variables such as age (47.2 vs. 41.7) and duration 
of illness (19.4 vs. 15) were different between the suicide and the 
Table 1 | A summary of subject characteristics included in suicide 
microarray analysis.
 Non-suicide Suicide
Number of subjects 38 45
Age 47.2 (1.6) 41.7 (1.6)
Sex (male) 55.3% 55.6%
Race (caucasian) 94.7% 95.6%
Bipolar disorder 65.8% 51.1%
Major depression 34.2% 48.9%
PMI 32.9 (2.5) 33.0 (2.3)
Brain pH 6.4 (0.05) 6.5 (0.04)
Duration of illness 19.4 (1.7) 15.0 (1.4)
Lifetime antipsychotics 11287 (4021) 4981 (1707)
For each variable, mean ± SE or percentage value is reported. PMI, postmortem 
interval.
4www.bioconductor.org
5http://david.abcc.ncifcrf.gov/
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qv = 4.2E-06) as shown in Figure 4A. A combined analysis of the 
microarrays showed that PRKCI expression levels were increased in 
the PFC of suicide victims as compared to the non-suicide subjects 
(FC: 1.14, qv = 0.015) shown in Figure 4B. Each microarray study 
has three probes for PRKCI and two studies (Study ID 2 and 3) did 
not show any changes in PRKCI expression while the rest of stud-
ies showed a tendency toward increase in expression. A combined 
analysis of microarrays demonstrated small but consensus changes 
in expression levels of PRKCI in the suicide group as compared to 
the non-suicide group.
until 20 years of age then stabilized until 49 years. In the PFC of suicide 
victims, MAPK9 expression levels were increased as compared to the 
non-suicide subjects (FC: 1.21, qv = 0.002) as shown in Figure 3B. 
Each study has two microarray probes for MAPK9 and most of the 
probes showed a tendency toward increase in expression. A combined 
analysis of microarrays revealed increased expression levels of MAPK9 
in the suicide victims as compared to the non-suicide controls.
A developmental expression pattern of the protein kinase C 
iota (PRKCI) gene showed a gradual decrease in the PFC of nor-
mal individuals ranging in age from birth to 49 years (r2 = 0.66, 
Figure 1 | The expression profiles of CAMK2B in the PFC of normal 
developing individuals and suicide victims. (A) The scatter plot with a locally 
weighted scatter plot smoothing (LOWESS) line demonstrates gradual 
decreases in expression levels of CAMK2B in the PFC of normal humans 
ranging in age from birth to 49 years. Points are colored by the predefined age 
groups: red = neonate, green = infant, blue = toddler, light blue = school age, 
pink = teenage, yellow = young adult, gray: adult. (B) The plot with fold changes 
and 95% confidence intervals shows consistent up-regulation of CAMK2B in 
the PFC of suicide victims as compared to the non-suicide controls across nine 
microarray studies. A combined analysis shown on the bottom represents the 
weighted fold change and 95% confidence intervals. Individual microarray 
probes for CAMK2B across multiple studies are shown on the left (Study ID and 
Affymetrix probe ID). Red circle: adjusted p < 0.05, Cyan circle: adjusted 
p > 0.05.
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CDK5, MAPK9, and PRKCI undergo age-dependent changes in 
expression in the PFC of normal individuals ranging in age from 
birth to 49 years. The expression levels of the same genes were 
increased in the PFC of suicide victims as compared to the non-
suicide controls. It is important to note that these genes have been 
implicated in the mechanisms of fear and stress-related disorders. 
Thus, these genes may also contribute to the pathophysiology of 
suicide via interactions with the fear and stress circuitry in the brain.
Here, we demonstrated the advantages of combining multiple 
microarray datasets to detect small but consensus changes in gene 
expression in the PFC of suicide victims. We found robust changes 
in gene expression in the PFC of normal individuals ranging in age 
from birth to 49 years, suggesting that chronological age is one of 
major factors affecting brain gene expression during development. 
We attempted to identify the genes that are associated with both 
chronological age and suicide phenotype in individuals with mood 
dIscussIon
The mechanisms of suicide are complex mediated by the interaction 
of multiple factors including genes and environment (Brezo et al., 
2008; Fiori et al., 2011). However, the search for specific genetic fac-
tors that contribute to the pathophysiology of suicide has been chal-
lenging (Mann et al., 2009; Tsai et al., 2011). Previous studies with 
rodent models with fear and stress suggested that kinase genes in 
the brain may play a role in fear and stress-related behavior (Kouzu 
et al., 2000; Li et al., 2002; Revest et al., 2005; Sananbenesi et al., 
2007; Hains et al., 2009). Although fear and stress may contribute 
to suicidal behavior in humans, expression profiles of those kinases 
genes in suicide brains have not been well-characterized. Thus, we 
investigated the expression profiles of the kinase genes using the 
microarray data from a well-characterized cohort of postmortem 
brains of mood disorder patients who died with suicide and with-
out suicide. We found that four kinase genes including CAMK2b, 
Figure 2 | The expression profiles of CDK5 in the PFC of normal 
developing individuals and suicide victims. (A) The scatter plot with a locally 
weighted scatter plot smoothing (LOWESS) line demonstrates inverted 
U-shape expression pattern of CDK5 in the PFC of normal humans ranging in 
age from birth to 49 years. Points are colored by the predefined age groups: 
red = neonate, green = infant, blue = toddler, light blue = school age, 
pink = teenage, yellow = young adult, gray: adult. (B) The plot with fold changes 
and 95% confidence intervals shows consistent up-regulation of CDK5 in the 
PFC of suicide victims as compared to the non-suicide controls across nine 
microarray studies. A combined analysis shown on the bottom represents the 
weighted fold change and 95% confidence intervals. Individual microarray 
probes for CDK5 across multiple studies are shown on the left (Study ID and 
Affymetrix probe ID). Red point: adjusted p < 0.05, Cyan point: adjusted 
p > 0.05.
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CAMK2 modulates catecholamine metabolism via phosphorylation 
of tyrosine hydroxylase in dopamine neurons (Seeman et al., 1976). 
Previous studies investigated the role of CAMK2A and CAMK2B 
in the postmortem brains of individuals with mood disorder. For 
example, a gene expression microarray study showed that CAMK2A 
expression levels were increased in the PFC of individuals with 
major depression (Tochigi et al., 2008). Another study replicated 
an up-regulation of CAMK2A in the PFC of individuals with major 
depression but not bipolar disorder using a real-time quantitative 
PCR (Novak et al., 2006). The authors showed that the expression 
levels of CaMK2A and CAMK2B were elevated in the depression 
subjects by 29 and 36%, respectively. Moreover, the increased levels 
in depression subjects were not altered by a history of antidepres-
sant medication in that study. Here, we classified the mood disorder 
subjects into either the suicide or the non-suicide group and we 
had a slightly higher number of depression cases in the suicide 
group. Although the increased levels of CAMK2B in the suicide 
disorder. A recent study showed the advantage of performing the 
genetic analysis using only mood disorder subjects with or without 
suicide attempts (Perlis et al., 2010). Thus, we have taken a similar 
approach of comparing suicide vs. non-suicide among the mood 
disorder subjects. Because we used only mood disorder samples, we 
were able to minimize the potential confounding effects of comor-
bid psychiatric disorders in our analysis.
Although many kinases are involved in a complex network of 
intracellular phosphorylation, previous studies suggested that mul-
tiple kinase genes such as PKC, CAMK, MAPK, and CDK play a 
significant role in regulating fear memories (Schafe et al., 2000; Li 
et al., 2002; Frankland et al., 2004; Lepicard et al., 2006; Sananbenesi 
et al., 2007; Bergstrom et al., 2011). CAMK2 including two splice 
variants, CaMK2A and CaMK2B, control dendritic growth and 
maturation in neurons, as well as phosphorylation of numer-
ous receptors including GABAA receptor (Churn and Delorenzo, 
1998) and NMDA glutamate receptor subunits (Rakic et al., 1994). 
Figure 3 | The expression profiles of MAPK9 in the PFC of normal 
individuals and of suicide victims. (A) The scatter plot with a locally 
weighted scatter plot smoothing (LOWESS) line demonstrates gradual 
increases in expression of MAPK9 in the PFC of normal humans ranging in age 
from birth to 49 years. Points are colored by the predefined age groups: 
red = neonate, green = infant, blue = toddler, light blue = school age, 
pink = teenage, yellow = young adult, gray: adult. (B) The plot with fold 
changes and 95% confidence intervals shows consistent up-regulation of 
MAPK9 in the PFC of suicide victims as compared to the non-suicide controls 
across nine microarray studies. A combined analysis shown on the bottom 
represents the weighted fold change and 95% confidence intervals. Individual 
microarray probes for MAPK9 across multiple studies are shown on the left 
(Study ID and Affymetrix probe ID). Red point: adjusted p < 0.05, Cyan point: 
adjusted p > 0.05.
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CDK5 pathway play a critical role in extinction of fear memory. 
Here, we found age-dependent changes in CDK5 expression: up-
regulation until 10 years of age and then gradual down-regulation 
until 49 years of age. This suggests that there is a sensitive period of 
CDK5 expression in the PFC during postnatal development. Thus, 
any disruptions in normal gene expression changes during devel-
opment may result in dysfunction of stress and fear mechanisms. 
Increases in CDK5 levels in the PFC of suicide victims further sug-
gest that fear learning and extinction mechanisms may be disrupted 
in the individuals with suicide.
MAPK signaling pathway is critical for cell division and dif-
ferentiation in the hippocampus as well as subsequent synaptic 
plasticity and memory formation (Sweatt, 2001). Importantly, 
MAPK has been shown to be critical for the formation of new fear 
memories, as well as for extinction and reconsolidation of fear 
memories (Schafe et al., 2000; Herry et al., 2006; Bergstrom et al., 
2011). These studies also support the role of neuronal plasticity 
group may have been influenced by higher number of depression 
samples in the suicide group, this is unlikely because we adjusted 
for the mood disorder effects in the multiple regression analysis of 
suicide. Given that CAMK2B could phosphorylate and influence 
the activity of many neurotransmitter receptors as well as neuronal 
growth and pruning, its altered expression in both developing and 
suicide brains suggests an important role in fear and stress.
CDK5 has been implicated in anxiety and stress-related disor-
ders that may require the promotion of the fear extinction process, 
which is defined as the learned reduction of fear. Some of the roles 
of CDK5 during neurodevelopmental processes, such as interac-
tions with distinct cytoplasmic and synaptic target molecules, may 
be related to the synaptic plasticity underlying memory consolida-
tion (Fischer et al., 2003). A study using genetic and pharmacologi-
cal approaches showed that extinction of fear memory requires the 
down-regulation of CDK5 in mice (Sananbenesi et al., 2007). The 
authors demonstrated that several key proteins associated with the 
Figure 4 | The expression profiles PRKCI in the PFC of normal 
developing individuals and suicide victims. (A) The scatter plot with a 
locally weighted scatter plot smoothing (LOWESS) line demonstrates gradual 
decreases in expression of PRKCI in the PFC of normal humans ranging in 
age from birth to 49 years. Points are colored by the predefined age groups: 
red = neonate, green = infant, blue = toddler, light blue = school age, 
pink = teenage, yellow = young adult, gray: adult. (B) The plot with fold 
changes and 95% confidence intervals shows consistent up-regulation of 
PRKCI in the PFC of suicide victims as compared to the non-suicide controls 
across nine microarray studies. A combined analysis shown on the bottom 
represents the weighted fold change and 95% confidence intervals. Individual 
microarray probes for PRKCI across multiple studies are shown on the left 
(Study ID and Affymetrix probe ID). Red point: adjusted p < 0.05, Cyan point: 
adjusted p > 0.05.
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